Magenta Therapeutics to Present Data at the 2022 American Society of Hematology (ASH) Annual Meeting
CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results